Literature DB >> 18155610

Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.

Sharon Elad1, Cyril Meyerowitz, Michael Y Shapira, Michael Glick, Menachem Bitan, Gail Amir.   

Abstract

In 2001, the World Health Organization (WHO) published its new classification of tumors of hematopoietic and lymphoid tissues, including an entity named posttransplantation lymphoproliferative disorder (PTLD). Because oral PTLD is of clinical relevance to oral health providers, the importance of distinguishing between PTLD and nontransplantation related lymphoma is outlined, and the clinical implications of oral PTLD are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18155610     DOI: 10.1016/j.tripleo.2007.06.020

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  4 in total

1.  Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer.

Authors:  A A Nelson; A M Harrington; S Kroft; M A Dahar; M Hamadani; B Dhakal
Journal:  Bone Marrow Transplant       Date:  2015-10-12       Impact factor: 5.483

Review 2.  Oral manifestations in transplant patients.

Authors:  Deepika Nappalli; Ashok Lingappa
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

Review 3.  Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders.

Authors:  R Karbasi-Afshar; S Taheri
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22

Review 4.  Oral complications in hematopoietic stem cell recipients: the role of inflammation.

Authors:  T M Haverman; J E Raber-Durlacher; W M H Rademacher; S Vokurka; J B Epstein; C Huisman; M D Hazenberg; J J de Soet; J de Lange; F R Rozema
Journal:  Mediators Inflamm       Date:  2014-04-10       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.